Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 11, 2001
April 8, 2020
37bc2102-9236-47bf-a1a3-6fbb42443ab7
Related Documents
Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications
Guidance DocumentJuly 13, 2001Center for Drug Evaluation and Research
Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Guidance DocumentDecember 1, 2000Center for Drug Evaluation and Research
Integration of Dose-Counting Mechanisms into MDI Drug Products
Guidance DocumentMarch 13, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.